Carlos Torres-Peris
Granada, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Loss of the extracellular protease ADAMTS1 reveals an antitumorigenic program involving the action of NIDOGEN-1 on macrophage polarization.
Journal: Oncoimmunology
Published: May 22, 2025
ADAMTS proteases and the tumor immune microenvironment: Lessons from substrates and pathologies.
Journal: Matrix biology plus
Published: August 21, 2020
Extracellular Protease ADAMTS1 Is Required at Early Stages of Human Uveal Melanoma Development by Inducing Stemness and Endothelial-Like Features on Tumor Cells.
Journal: Cancers
Published: February 05, 2020
Inhibition of ADAMTS1 Expression by Lentiviral CRISPR/Cas9 Gene Editing Technology.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: August 30, 2019
ADAMTS1 protease is required for a balanced immune cell repertoire and tumour inflammatory response.
ADAMTS1 protease is required for a balanced immune cell repertoire and tumour inflammatory response.
Journal: Scientific reports
Published: January 31, 2018
Stroma-derived but not tumor ADAMTS1 is a main driver of tumor growth and metastasis.
Journal: Oncotarget
Published: February 24, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026